Use App
Trending
News
Earnings
Newsletters
Work With Us
All
DIA
0.54%
SPY
0.21%
QQQ
0.29%
Trending
ASTS
6.40%
HOOD
7.71%
MSFT
0.60%
SPHL
677.78%
RILY
25.60%
MLEC
110.48%
BBAI
1.12%
GLXY
13.13%
RDDT
9.56%
NCEW
4.78%
ASTS
6.40%
HOOD
7.71%
MSFT
0.60%
SPHL
677.78%
RILY
25.60%
MLEC
110.48%
BBAI
1.12%
GLXY
13.13%
RDDT
9.56%
NCEW
4.78%
home
Symbol
CNSP
CNSP
Cns Pharmaceuticals Inc
7,946
Mkt Cap
$3.85M
Volume
997,027.00
52W High
$114.00
52W Low
$4.93
PE Ratio
-0.11
CNSP Fundamentals
Price
$7.35
Prev Close
$6.20
Open
$6.79
50D MA
$6.51
Beta
0.98
Avg. Volume
19,901.95
EPS (Annual)
-$466.44
P/B
0.36
Rev/Employee
$0.00
PE Ratio
-0.11
Loading...
Loading...
Feed
News
Sentiment
Fundamentals
Info
News
all
press releases
CNS Pharmaceuticals Stock Declines On Wider Q1 Loss: But Retail Stays Unmoved
The company intends to commence the phase 2 study of its lead program, TPI 287, to treat Glioblastoma Multiforme (GBM) by year-end.
Stocktwits
·
8mo ago
Full Article
<
...
1
>
Latest CNSP News
View
Top Discussions
top
active
trending
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile